Insider Shareholders with Direct Ownership of Mereo Biopharma Group PLC (MREO)
This section provides a comprehensive overview of the insiders with direct ownership of Mereo Biopharma Group PLC (MREO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Mereo Biopharma Group plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Denise Scots Knight
Chief Executive Officer |
470,150 | 221,642 | 808,921 $2.98 Million | 6 |
Sep 13, 2024
Reduced 6.91%
|
|
Charles Sermon
General Counsel |
164,000 | 77,315 | 219,061 $808,335 | 6 |
Sep 13, 2024
Reduced 8.73%
|
|
Christine Ann Fox
Chief Financial Officer |
150,000 | 70,715 | 89,285 $329,461 | 6 |
Sep 13, 2024
Reduced 17.67%
|
|
John A. Lewicki
Chief Scientific Officer |
115,000 | 40,373 | 78,630 $290,144 | 6 |
Sep 13, 2024
Reduced 12.21%
|
| 436,666 | 349,545 | 50,475 $186,252 | 8 |
Sep 13, 2024
Reduced 62.47%
|
|
| 25,050 | 0 | 25,050 $92,434 | 1 |
Jun 17, 2024
Added 50.0%
|
|
| 105,244 | 105,244 | 0 $0 | 2 |
Aug 22, 2024
Reduced 100.0%
|